Preview

PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology

Advanced search
Fullscreen

For citation:


Kolbin A.S., Vilyum I.A., Proskurin M.A., Balykina Y.E. BUDGET IMPACT ANALYSIS IN THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD. PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology. 2015;8(1):39-46. (In Russ.) https://doi.org/10.17749/2070-4909.2015.8.1.039-046

Views: 607


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)